Description:

CALGB Randomization (CALGB 49903) NCT00053339 Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A73D2B92-2BAF-4794-E034-0003BA0B1A09

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A73D2B92-2BAF-4794-E034-0003BA0B1A09

Keywords:
Versions (4) ▾
  1. 12/18/14
  2. 1/9/15
  3. 7/5/15
  4. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CALGB Randomization (CALGB 49903) NCT00053339

No Instruction available.

  1. StudyEvent: CALGB Randomization (CALGB 49903)
    1. No Instruction available.
Header
Protocol Administration
Patient Demographics / Pre-treatment Characteristics
Patient Race/Ethnicity
Sex
Method of Payment
Performance Status
Certification Of Eligibility
Patient eligible? (STRATIFICATION FACTORS)
Registration data
ASSIGNED TREATMENT ARM
Ccrr Module For Calgb Randomization (calgb 49903)

Similar models